(UroToday.com) In a session of the Best Prostate Cancer Poster Presentations at this year’s Society of Urologic Oncology (SUO) virtual annual meeting, Dr. Michael Schweizer presented there worked examining the role of apalutamide in lower-risk prostate cancer.